Hyperthyroidism affects arterial stiffness, plasma NT‐pro‐B‐type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease

References

• Chopra I. J., Solomon D. H. Pathogenesis of hyperthyroidism. Annu Rev Med 1983; 34: 267–81
   Google Scholar
• Klein I., Ojamaa K. Thyroid hormone and the cardiovascular systeme. N Engl J Med 2001; 344: 501–9
   PubMed Web of Science ®Google Scholar
• Polikar R., Burger A. G., Scherrer U., Nicod P. The thyroid and the heart. Circulation 1993; 87: 1435–41
   PubMed Web of Science ®Google Scholar
• Kahaly G. J., Dillmann W. H. Thyroid hormone action in the heart. Endocr Rev 2005; 26: 704–28
   PubMed Web of Science ®Google Scholar
• Toft A. D., Boon N. A. Thyroid disease and the heart. Heart 2000; 84: 455–60
   PubMed Web of Science ®Google Scholar
• Volzke H., Robinson D. M., Schminke U., Ludemann J., Rettig R., Felix S. B., et al. Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 2004; 89: 2145–9
   Google Scholar
• Inaba M., Henmi Y., Kumeda Y., Ueda M., Nagata M., Emoto M., et al. Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients. Biomed Pharmacother 2002; 56: 241–6
   Google Scholar
• Czarkowski M., Hilgertner L., Powalowski T., Radomski D. The stiffness of the common carotid artery in patients with Graves' disease. Int Angiol 2002; 21: 152–7
   Google Scholar
• Palmieri E. A., Fazio S., Palmieri V., Lombardi G., Biondi B. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of β1‐adrenergic blockade. Eur J Endocrinol 2004; 150: 757–62
   Google Scholar
• O'Rourke M. F., Kelly R. P. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens 1993; 11: 327–37
   PubMed Web of Science ®Google Scholar
• Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B‐type natriuretic peptide in comparison with those of A‐type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195–203
   PubMed Web of Science ®Google Scholar
• Shapiro B. P., Chen H. H., Burnett J. C., Redfield M. M. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc 2003; 78: 481–6
   PubMed Web of Science ®Google Scholar
• Mair J., Hammerer‐Lercher A., Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39: 571–88
   PubMed Web of Science ®Google Scholar
• Schultz M., Faber J., Kistorp C., Jarlov A., Pedersen F., Wiinberg N., et al. N‐terminal‐pro‐B‐type natriuretic peptide (NT‐pro‐BNP) in different thyroid function states. Clin Endocrinol 2004; 60: 54–9
   PubMed Web of Science ®Google Scholar
• Wei T., Zeng C., Tian Y., Chen Q., Wang L. B‐type natriuretic peptide in patients with clinical hyperthyroidism. J Endocrinol Invest 2005; 28: 8–11
   PubMed Web of Science ®Google Scholar
• Kohno M., Horio T., Yasunari K., Yokokawa K., Ikeda M., Kurihara N., et al. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 1993; 42: 1059–64
   PubMed Web of Science ®Google Scholar
• McCullough P. A., Omland T., Maisel A. S. B‐type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003; 4: 72–80
   PubMedGoogle Scholar
• Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Biochemical diagnosis of impaired left ventricular ejection fraction—comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT‐proBNP). Clin Chem Lab Med 2004; 42: 159–63
   Web of Science ®Google Scholar
• Choi Y. H., Chung J. H., Bae S. W., Lee W. H., Jeong E. M., Kang M. G., et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis 2005; 16: 135–9
   Google Scholar
• Buckberg G. D., Towers B., Paglia D. E., Mulder D. G., Maloney J. V. Subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1972; 64: 669–84
   PubMed Web of Science ®Google Scholar
• Dorr M., Volzke H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol 2005; 30: 199–216
   PubMedGoogle Scholar
• Osman F., Gammage M. D., Franklyn J. A. Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 2002; 12: 483–7
   PubMed Web of Science ®Google Scholar
• Chen C. H., Nevo E., Fetics B., Pak P. H., Yin F. C., Maughan W. L., et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 1997; 95: 1827–36
   PubMed Web of Science ®Google Scholar
• Pauca A. L., O'Rourke M. F., Kon N. D. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932–7
   PubMed Web of Science ®Google Scholar
• O'Rourke M., Pauca A., Kon N. Generation of ascending aortic from radial artery pressure waveform. J Am Coll Cardiol 2002; 39 suppl B: 177B
   Google Scholar
• Wilkinson I. B., MacCallum H., Flint L., Cockcroft J. R., Newby D. E., Webb D. J. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000; 525: 263–70
   PubMed Web of Science ®Google Scholar
• Bodlaj G., Berg J., Biesenbach G. Diurnal variation of arterial stiffness and subendocardial perfusion noninvasively assessed using applanation tonometry in healthy young men. Wien Klin Wochenschr 2005; 117: 348–52
   PubMed Web of Science ®Google Scholar
• Bland J. M., Altman D. G. Statistics Notes. Measurement error. BMJ 1996; 313: 744
   PubMed Web of Science ®Google Scholar
• Obuobie K., Smith J., John R., Davies J. S., Lazarus J. H. The effects of thyrotoxicosis and its treatment on central arterial stiffness. Eur J Endocrinol 2002; 147: 35–40
   Google Scholar
• O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15: 339–47
   PubMed Web of Science ®Google Scholar
• Liang F., Webb P., Marimuthu A., Zhang S., Gardner D. G. Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin‐dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 2003; 278: 15073–83
   PubMed Web of Science ®Google Scholar
• Noh J. Y., Hamada N., Inoue Y., Abe Y., Ito K., Ito K. Thyroid‐stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin‐binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid 2000; 10: 809–13
   PubMed Web of Science ®Google Scholar
• Wilkinson I. B., Franklin S. S., Hall I. R., Tyrrell S., Cockcroft J. R. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001; 38: 1461–6
   PubMed Web of Science ®Google Scholar
• Chen J. L., Chiu H. W., Tseng Y. J., Chu W. C. Hyperthyroidism is characrerized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol 2006; 64: 611–6
   PubMed Web of Science ®Google Scholar
• Ojamaa K., Klemperer J. D., Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996; 6: 505–12
   PubMed Web of Science ®Google Scholar
• Levey G. S., Klein I. Catecholamine‐thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 1990; 88: 642–6
   PubMed Web of Science ®Google Scholar
• Benetos A., Waeber B., Izzo J., Mitchell G., Resnick L., Asmar R., et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002; 15: 1101–8
   PubMed Web of Science ®Google Scholar
• Peters A., Ehlers M., Blank B., Exler D., Falk C., Kohlmann T., et al. Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 2000; 160: 1993–9
   Google Scholar
• Fazio S., Palmieri E. A., Lombardi G., Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004; 59: 31–50
   PubMedGoogle Scholar
• Cohn J. N. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation 2006; 113: 601–3
   PubMed Web of Science ®Google Scholar
• Weber T., Auer J., O'Rourke M. F., Kvas E., Lassnig E., Lamm G., et al. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005; 26: 2657–63
   PubMed Web of Science ®Google Scholar